Access cutting-edge soft tissue sarcoma treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access soft tissue sarcoma specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related soft tissue sarcoma treatment provided free
In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG 20 and ifosfamide in combination with radiation as neoadjuvant therapy. In phase I of the study, up to 5 dose levels will be tested to find the recommended phase II dose (RP2D), after which patients enrolling to phase II will be treated at that dose level to assess efficacy.
Sponsor: Washington University School of Medicine
Check if you qualify for this soft tissue sarcoma clinical trial in Aurora, CO
If you're searching for soft tissue sarcoma treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced soft tissue sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.